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Objective. We evaluated the use of a one-week ambulatory pessary trial in predicting patients’ postoperative outcomes for occult
stress incontinence. Methods. Patients with anterior vaginal wall prolapse were oﬀered a pessary trial to predict response to
reconstruction. We performed a retrospective review of 4 years of cases. All patients underwent a detailed evaluation including
videourodynamics with and without pessary reduction. Results.Twenty-six patients completed the 1-week pessary trial. Ten (38%)
women showing noevidence ofstressurinaryincontinence (SUI)underwent surgical repairof prolapsewithout anti-incontinence
procedure. None of these patients had SUI postoperatively. Sixteen women (61%) had occult stress urinary incontinence on
evaluation and underwent concurrent sling procedure. Three (19%) of these patients were identiﬁed by the pessary trial alone.
Twenty-ﬁve of the 26 patients were without clinical stress incontinence at a mean follow up of 12 months (range 4–37 months).
The pessary trial correctly predicted persistent urgency in six patients and persistent frequency in ﬁve. No patients with SUI
or persistent voiding diﬃcult were missed in a pessary trial. Conclusion. An ambulatory pessary trial is an eﬀective, easy, and
inexpensive method to approximate anatomic results achieved by surgery under real-life conditions. In our series, 20% of patients
with occult SUI were identiﬁed by pessary trial alone.
1.Introduction
Each year, approximately 200,000 women undergo surgical
treatment for pelvic organ prolapse (POP) in the United
States [1]. Of these women, approximately 21% included
urinary incontinence procedures, for an annual cost of
greater than $1 billion for surgical repair of prolapse [2]. The
demand for POP repair is expected to increase as the U.S.
population ages and life expectancies increase.
The central question in the preoperative evaluation of
a patient with POP is to estimate functional outcome once
the anatomy is corrected. It is well documented that stress-
continent women with advanced POP may develop stress
urinary incontinence (SUI) following prolapse reduction [3,
4].Itisthoughtthatcorrectionoftheanatomywillunkinkor
decrease resistance to the urethra, thereby unmasking intrin-
sic sphincteric deﬁciency. Regardless of objective outcome
of prolapse repair, patient satisfaction with surgery is highly
correlated with patient expectations preoperatively [5].
There are no clear guidelines regarding concurrent anti-
incontinence procedures during surgical prolapse repair.
Some surgeons place a sling or perform a retropubic suspen-
sion “prophylactically” at the time of all signiﬁcant prolapse
surgery [6, 7]. Others feel this exposes the patient to addi-
tional morbidity without proven beneﬁt [8, 9]. Alternatively,
it is extremely discouraging for both the patient and surgeon
when a patient develops new-onset SUI after having just
undergone a major vaginal reconstruction. An additional
anti-incontinence procedure necessitates a repeat trip to
the operating room, repeat anesthesia, additional recovery
period, and surgery in a previously operated ﬁeld.
Ideally one could predict the need for anti-incontinence
surgery at the time of prolapse reduction in women who do
not have stress incontinence preoperatively, as well as predict
improvement in other urinary symptoms.
Our study, while not attempting to deﬁnitively answer
the complex issue of concomitant anti-incontinent surgery
during prolapse repair, aims to describe our experience with2 Obstetrics and Gynecology International
an ambulatory pessary trial in addition to preoperative uro-
dynamic testing (UDS). Our primary objective is to deter-
mine if an ambulatory pessary trial can identify women with
occult stress urinary incontinence before prolapse repair.
There is limited literature examining outcomes with an
ambulatory pessary trial. This exercise approximates the
anatomic result achieved by surgery under real-life condi-
tions.Thetrialallowsforidentiﬁcationofoccultstressincon-
tinence during activities of daily life in the patient’s home
environment and allows appropriate expectations regarding
functional urinary symptoms after surgery. We present the
study not as the deﬁnitive answer to this controversial surgi-
cal question but rather as a tool in the preoperative assess-
ment which we have found clinically useful in our practice.
2. Methods
Following Institutional Review Board approval, a retro-
spective chart review of patients in the Albany Medical
CenterDivisionofUrologyClinicandUrodynamicDatabase
was conducted. The electronic medical records of those
patients who underwent a pessary trial with a subsequent
sling/suspension procedure between June 2005 and February
2009 were identiﬁed. All data was tabulated in a deidentiﬁed
format. Data was collected on patient demographics and the
results of urodynamic studies. VUDS data included intra-
abdominal, detrusor, and intravesical pressures as well as
ﬁll rate at both baseline and maximal capacity. Criteria
for inclusion consisted of Baden-Walker grade 2 or higher
anterior vaginal wall prolapse and an unresolved diagnostic
concern(occultstressincontinence,incompleteemptying,or
urge incontinence) and the capacity to retain a pessary.
Allpatientsunderwentadetailedhistory,physicalinclud-
ing pelvic exam, including meticulous multichannel VUDS
withandwithoutreductionpreoperatively.Urodynamictest-
ing was conducted with a Triton Multichannel Urodynamics
Monitor (Laborie, Inc., Burlington, Vt, USA) according
to the speciﬁcations of the ICS [10]. The urodynamic
assessment was performed with the patient sitting with SUI
evaluatedbyhavingthepatientcoughandperformaValsalva
maneuver at 200cc and capacity. Vesical leak point pressure
was deﬁned as the minimum amount of pressure necessary
to produce visible or ﬂuoroscopic urine leakage. Pressure
ﬂow studies were conducted as patients voided after reaching
functional capacity. Urodynamic stress incontinence was
deﬁned as observable urine leakage during valsalva without
associated detrusor overactivity.
A split speculum technique with the patient in the litho-
tomy position was utilized to evaluate the extent of the
prolapse for classiﬁcation according to the Baden and Walker
criteria [11]. Urethral hypermobility was deﬁned as a change
intheurethralanglebetweenrestandstrainingof30degrees.
Patients who met inclusion criteria were oﬀered a home
pessary trial to predict response to reconstruction. The pes-
sary, either Gehrung, donut, or ring, was ﬁtted so it would be
large enough to remain in place during periods of increased
intraabdominal pressure but loose enough to avoid urethral
obstruction. Patients attempted an ambulatory pessary trial
for a minimum of one week prior to surgical intervention.
Table 1: Patients demonstrating SUI, UUI, urgency, frequency, and
nocturia preoperatively during UDS, pessary trial, and postopera-
tively.
Preoperative
clinically UDS Ambulatory
pessary trial
Postoperative
clinically
%( N ) %( N ) %( N ) %( N )
SUI 50 (13) 23 (6) 61 (16) 4 (1)
UUI 85 (22) 38 (10) 15 (4) 23 (6)
Urgency 85 (22) 23 (6) 23 (6)
Frequency 81 (21) 19 (5) 19 (5)
Nocturia 69 (18) 4 (1)
Table 2: Procedures performed for correction of prolapse and
urinary incontinence.
Procedures N
Colpocleisis—Le Fort 1
Anterior colporrhaphy 15
Combined AP colporrhaphy 5
Colpopexy—abdominal approach 2
Colpopexy—intravaginal approach 2
Sling repair 14
Laparoscopic colpopexy 1
Patients were instructed to note their symptoms with the
pessaries in place for the duration of the week, while
performingalloftheirusualactivities.Patientswerefollowed
with respect to clinical symptoms.
Surgical repair of the prolapse was performed by a single
surgeon; an additional anti-incontinence procedure, TOT
mid-urethral sling, was performed if SUI was identiﬁed
preoperatively by the ambulatory pessary trial. All patients
received a postoperative examination, systematic interview
of voiding symptoms and measurement of postvoid residual
(PVR). We do not routinely use postoperative urodynamic
evaluation. Outcome was based on patient report of leakage
postoperatively.
3. Results
Between June 2005 and February 2009, 41 patients accepted
the home pessary trial. Of these women, 26 were able
to retain their pessary for at least one week; subsequent
analysis is based on this subset. The mean age of the study
subjects was 65 (range 44 to 80). Twenty-four of the women
presented with a cystocele, while 10 had a rectocele. The
median cystocele grade was Baden-Walker 2 (range 2–4),
while the median rectocele grade was 1.8. The median vault
grade was 2 (range 2–4), while the mean degree of urethral
hypermobilitywas39(range0–45).Approximately62%(16)
of the patients had a grade 2 cystocele, while 27% (7) had a
grade 3. Only one patient (4%) had a grade 4 cystocele.
Ten (38%) women showed no evidence of SUI by
pessary trial, clinical report, VUDS, or physical exam and
underwent surgical repair of their prolapse without anObstetrics and Gynecology International 3
Table 3: Systemic clinic interview.
(1) How often do you usually urinate during the day?
(2) How many times do you usually urinate during the day?
(3) How often do you usually urinate during the night?
(4) How many times do you usually urinate at night? (from time you go to bed until time you wake up for the day)
(5) What is the reason that you usually urinate?
(6) Once you get the urge or desire to urinate, how long can you usually postpone it comfortably?
(7) How often do you get a sudden urge or desire to urinate that makes you want to stop what you are doing and rush to the
bathroom?
(8) How often do you get a sudden urge or desire to urinate that makes you want to stop what you are doing and rush to the
bathroom but you do not get there in time? (leak urine or wet pads)
(9) How often do you experience urine leakage when you sneeze or cough?
(10) How often do you experience urine leakage when you lift and bend?
(11) How often do you experience urine leakage when you change positions?
(12) How often do you experience urine leakage related to physical activity?
(13) How often do you wet yourself, your pads or your clothes without any awareness of how or when it happened?
(14) In your opinion how good is your bladder control?
(15) How often do you have a sensation of not emptying your bladder completely?
(16) How often do you stop and start during urination?
(17) How often do you have a weak urinary stream?
(18) How often do you push or strain to begin urination?
(19) How bothered are you by your bladder symptoms?
accompanying anti-incontinence procedure. None of these
women had stress urinary incontinence postoperatively. No
intraoperative complications occurred during the opera-
tions, listed in Table 2.
Sixteen (61%) women were found to have occult stress
urinary incontinence by pessary trial, clinical report, VUDS,
or physical exam and underwent a concomitant vaginal
sling procedure (Table 3). Three (19%) of these sixteen were
identiﬁed by the pessary trial alone; their SUI was not
detected with VUDS (Table 1).
The ambulatory pessary trial correctly predicted persis-
tent urgency and persistent frequency in 5 and 6 patients,
respectively. Overall, signiﬁcant decreases in clinical SUI and
urge urinary incontinence (UUI) were seen postoperatively
(Table 1).
Twenty-ﬁve of the 26 patients who qualiﬁed for the study
were without clinical stress incontinence after surgery at a
mean followup of 12 months (range 4–37 months).
Therewerenopatientswithoccultstressurinaryinconti-
nence or persistent voiding diﬃculty whose symptoms were
missed in a successful pessary trial.
4. Discussion
OccultSUIisarelativelycommonoccurrenceinwomenwith
severe pelvic organ prolapse and is critical to identify when
planningasurgicalrepair.Ourstudyconﬁrmsthisﬁnding,as
over 60% of the patients had evidence of SUI, 20% of which
was occult and identiﬁed by pessary trial only.
The one failure with postoperative SUI occurred in the
sling group; although initially dry postoperatively, marked
noncompliance with postoperative activity restrictions likely
resulted in sling migration. She was later rendered dry by
transurethral bulking agent.
Several studies assert that preoperative VUDS with
prolapsed reduction is useful for estimating the risk of
developing postoperative incontinence [4, 9, 12]. Surgeons
adhering to this philosophy will perform an additional anti-
incontinence procedure only in those who show urodynamic
stress incontinence. Liang et al. reported that none of
their 30 patients who were stress-continent during pessary-
reduced urodynamic trial developed SUI postoperatively.
They concluded that concomitant anti-incontinence surgery
is not necessary in this group [12]. Klutke and Ramos
found the same results and arrived at a similar conclusion
in a retrospective review of 70 patients [13]. Alternatively,
patients who do develop incontinence during prolapse-
reduced urodynamics are prone to develop stress inconti-
nence postoperatively if an anti-incontinence procedure is
not performed concomitantly [14].
However, the study by Visco et al. showed preoperative
use of VUDS is not 100 percent sensitive in identifying
occult SUI and its sensitivity is also inﬂuenced by which
reduction method is used [4]. The pessary was found to
be the least sensitive method in detection of masked stress
incontinenceduringurodynamictesting,whilethespeculum
wasmostsensitive[4].Althoughcommonlyused,thevaginal
gauze pack was shown in a single institution series to not be
particularly successful at unmasking SUI [14]. Although not
particularly sensitive for stress incontinence, preoperative
pessary testing has been shown to be highly predictive of
postoperative voiding function [8]. Reduction by pessary,
however, is relatively easy to perform, convenient, and
comfortable for most women [9].4 Obstetrics and Gynecology International
In our retrospective review, we conﬁrmed our hypothesis
that an ambulatory pessary trial increases the detection
rate of SUI. Multichannel VUDS has been shown to detect
most cases of occult SUI; however, a certain percentage
will be missed, (20% in our study.) We hypothesize that
this failure may be due to the nonphysiologic nature of
the UDS testing environment and unmasked by both the
length of time and diﬀerent conditions an ambulatory trial
a l l o w s .I na ne ﬀort to reduce the hardships of missing
occult SUI, we suggest a home pessary trial for women
with severe pelvic organ prolapse with no evidence of SUI
during VUDS. By having the anti-incontinence procedure
performedconcurrentlywiththeprolapserepair,womencan
avoid the risk and signiﬁcant dissatisfaction associated with
an additional operation.
InadditiontodetectingoccultSUIthatwouldmostlikely
otherwise be missed, a home pessary trial confers a number
of other beneﬁts. It can help predict persistent incomplete
emptying, as well as persistent UUI, thereby providing
women with appropriate postoperative expectations. In our
trial, none of the patients with either of these two conditions
were missed during an ambulatory pessary trial. Rather than
trying to address refractory UUI postoperatively, a low-cost,
low-morbidity pessary trial can provide the clinician and
patient with essential prognostic information.
Our study does contain several limitations, namely, the
small sample size, retrospective data collection, reliance on
systemic interview rather than standardized pad weight, and
limited followup. Also as noted in the results, a signiﬁcant
number of patients were unable to retain for the one-
week pessary trial, which does limit its use in preoperative
evaluationinpatientswithperinealrelation.Previousstudies
addressing pessary use report a success rate of 50–71%,
depending on patient type and length of trial [15–17].
Althoughtheone-weektrialutilizedinthisstudyappearedto
suﬃce, the ideal length of a home pessary trial has not been
determined.Thediﬀerencesbetweenpessarytypescouldalso
be a cofounding variable although previous studies found no
diﬀerence on VUDS between a Smith-Hodge pessary and a
ring pessary [18].
Given that the prevalence of pelvic organ prolapse and
demand for surgical repair is likely to increase; further
research is needed to address the preoperative evaluation
with larger study populations, prospective data and extended
followup. The need for continued research to deﬁne appro-
priatepreoperativeevaluationandevaluateresultsofsurgical
repair for this common condition is obvious.
5. Conclusions
A properly ﬁtted pessary will approximate the anatomic
result achieved by surgery during activities of daily life.
This reversible trial aids in the decision to perform anti-
incontinence procedures and in setting appropriate postop-
erative expectations regarding urgency and emptying ability.
In our series, 20% of patients in our stress incontinent
group were identiﬁed by pessary trial alone. The pessary is
a valuable diagnostic tool, and we suggest a home pessary
trial for women with pelvic organ prolapse with no evidence
of SUI during VUDS.
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